MP Materials Corp. / DE
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and the Board of Directors
MP Materials Corp.:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated balance sheets of MP Materials Corp. and subsidiaries (the Company) as of December 31, 2025 and 2024, the related consolidated statements of operations, comprehensive income (loss), changes in redeemable preferred stock and stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2025, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2025, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Accounting for the Price Protection Agreement
As described in Notes 2 and 3 to the consolidated financial statements, on July 9, 2025, the Company entered into a series of definitive agreements with the U.S. Government. These transactions involved the Company issuing several financial instruments, including Series A Preferred Stock, a Warrant, a Samarium Project Loan and a Price Protection Agreement (PPA). The PPA is a financial instrument recorded on the consolidated balance sheet as a price protection agreement upfront asset with an initial value of $218.6 million.
We identified the evaluation of the accounting for the PPA as a critical audit matter. Challenging auditor judgment was involved in assessing the PPA features, which required interpretation of complex contract terms within the PPA and the evaluation of management’s judgment in applying the relevant technical accounting guidance.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the Company’s initial accounting for the PPA. We obtained and read the PPA and related agreements noted above to identify contract terms relevant to the application of technical accounting guidance. We inquired of management regarding the business purpose of the transaction. We analyzed the key contract terms of the PPA, evaluated management’s identification of such terms for completeness and accuracy, including identification of units of account, and assessed the Company’s application of the relevant accounting literature to account for the key contract terms of the PPA.
/s/ KPMG LLP
We have served as the Company’s auditor since 2017.
Denver, Colorado
February 26, 2026
CONSOLIDATED BALANCE SHEETS
| December 31, | ||
|---|---|---|
| (U.S. dollars in thousands, except share and per share data) | 2025 | 2024 |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $1,166,011 | $282,442 |
| Short-term investments | 664,275 | 568,426 |
| Total cash, cash equivalents and short-term investments | 1,830,286 | 850,868 |
| Trade accounts receivable, net of allowance for credit losses of $0 and $0, respectively (including related party) | 14,642 | 18,645 |
| Income taxes receivable | 1,004 | 23,672 |
| Other receivables | 131,038 | 20,599 |
| Inventories | 171,560 | 107,905 |
| Prepaid expenses and other current assets | 17,271 | 9,633 |
| Total current assets | 2,165,801 | 1,031,322 |
| Non-current assets | ||
| Property, plant and equipment, net | 1,369,817 | 1,251,496 |
| Inventories | 80,539 | 19,031 |
| Price protection agreement upfront asset, net | 209,668 | — |
| Other non-current assets | 38,335 | 31,709 |
| Total non-current assets | 1,698,359 | 1,302,236 |
| Total assets | $3,864,160 | $2,333,558 |
| Liabilities, redeemable preferred stock and stockholders’ equity | ||
| Current liabilities | ||
| Accounts and construction payable | $36,655 | $23,562 |
| Accrued liabilities | 95,086 | 64,727 |
| Current portion of long-term debt | 67,411 | — |
| Deferred revenue | 74,301 | 56,880 |
| Other current liabilities | 25,596 | 18,850 |
| Total current liabilities | 299,049 | 164,019 |
| Non-current liabilities | ||
| Long-term debt, net of current portion | 931,330 | 908,729 |
| Deferred revenue | 83,889 | 43,120 |
| Deferred government grant | 22,101 | 20,087 |
| Deferred investment tax credit | 26,860 | 25,502 |
| Deferred income taxes | 51,558 | 85,309 |
| Other non-current liabilities | 57,005 | 31,912 |
| Total non-current liabilities | 1,172,743 | 1,114,659 |
| Total liabilities | 1,471,792 | 1,278,678 |
| Commitments and contingencies (Note 13) | ||
| Redeemable preferred stock: | ||
| Series A cumulative perpetual convertible preferred stock ($0.0001 par value, 400,000 and zero shares authorized, issued and outstanding as of December 31, 2025, and December 31, 2024, respectively; aggregate liquidation preference of $413,489 and zero as of December 31, 2025, and December 31, 2024, respectively) | 413,611 | — |
| Stockholders’ equity: | ||
| Preferred stock, undesignated ($0.0001 par value, 49,600,000 and 50,000,000 shares authorized as of December 31, 2025, and December 31, 2024, respectively, zero issued and outstanding in either year) | — | — |
| Common stock ($0.0001 par value, 450,000,000 shares authorized, 192,607,429 and 178,445,570 shares issued, and 177,357,647 and 163,195,788 shares outstanding, as of December 31, 2025, and December 31, 2024, respectively) | 19 | 18 |
| Additional paid-in capital | 1,970,970 | 961,434 |
| Retained earnings | 234,428 | 320,302 |
| Accumulated other comprehensive income | 387 | 173 |
| Treasury stock, at cost, 15,249,782 shares for both periods | (227,047) | (227,047) |
| Total stockholders’ equity | 1,978,757 | 1,054,880 |
| Total liabilities, redeemable preferred stock and stockholders’ equity | $3,864,160 | $2,333,558 |
CONSOLIDATED STATEMENTS OF OPERATIONS
| For the year ended December 31, | |||
|---|---|---|---|
| (U.S. dollars in thousands, except share and per share data) | 2025 | 2024 | 2023 |
| Revenue (including related party) | $224,441 | $203,855 | $253,445 |
| Price protection agreement income | 51,016 | — | — |
| Operating costs and expenses: | |||
| Cost of sales (excluding depreciation, depletion and amortization) (including related party) | 192,789 | 192,586 | 92,714 |
| Selling, general and administrative | 112,066 | 83,299 | 79,245 |
| Depreciation, depletion and amortization | 89,267 | 78,057 | 55,709 |
| Start-up costs | 4,286 | 5,684 | 21,330 |
| Advanced projects and development | 24,208 | 9,307 | 14,932 |
| Other operating costs and expenses | 2,215 | 4,348 | 7,234 |
| Total operating costs and expenses, net | 424,831 | 373,281 | 271,164 |
| Operating loss | (149,374) | (169,426) | (17,719) |
| Interest expense, net | (31,481) | (23,010) | (5,254) |
| Gain on early extinguishment of debt | — | 52,911 | — |
| Other income, net | 63,081 | 46,178 | 56,048 |
| Income (loss) before income taxes | (117,774) | (93,347) | 33,075 |
| Income tax benefit (expense) | 31,900 | 27,923 | (8,768) |
| Net income (loss) | $(85,874) | $(65,424) | $24,307 |
| Earnings (loss) per common share: | |||
| Basic | $(0.50) | $(0.39) | $0.14 |
| Diluted | $(0.50) | $(0.57) | $0.14 |
| Weighted-average shares outstanding: | |||
| Basic | 170,126,753 | 166,840,611 | 177,181,661 |
| Diluted | 170,126,753 | 169,882,640 | 178,152,212 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
| For the year ended December 31, | |||
|---|---|---|---|
| (U.S. dollars in thousands) | 2025 | 2024 | 2023 |
| Net income (loss) | $(85,874) | $(65,424) | $24,307 |
| Other comprehensive income (loss), net of tax: | |||
| Change in net unrealized gains (losses) on available-for-sale securities and other | 214 | 28 | (44) |
| Total comprehensive income (loss) | $(85,660) | $(65,396) | $24,263 |
CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
| Redeemable Preferred Stock · Stockholders’ Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (U.S. dollars in thousands, except share data) · Series A Convertible Preferred Stock · Preferred Stock, Undesignated · Common Stock · Additional Paid-in Capital · Retained Earnings · Accumulated Other Comprehensive Income · Treasury Stock · TotalStockholders’Equity | |||||||||||
| Shares · Amount · Shares · Amount · Shares · Amount | |||||||||||
| Balance as of January 1, 2023 | — | $— | — | $— | 177,706,608 | $18 | $951,008 | $361,419 | $189 | $— | $1,312,634 |
| Stock-based compensation | — | — | — | — | 472,047 | — | 27,104 | — | — | — | 27,104 |
| Shares used to settle payroll tax withholding | — | — | — | — | (248,776) | (1) | (7,184) | — | — | — | (7,185) |
| Common stock issued to acquire intangible asset | — | — | — | — | 152,504 | — | 8,963 | — | — | — | 8,963 |
| Net income | — | — | — | — | — | — | — | 24,307 | — | — | 24,307 |
| Other comprehensive loss, net of tax | — | — | — | — | — | — | — | — | (44) | — | (44) |
| Balance as of December 31, 2023 | — | — | — | — | 178,082,383 | 17 | 979,891 | 385,726 | 145 | — | 1,365,779 |
| Stock-based compensation | — | — | — | — | 662,887 | 1 | 23,505 | — | — | — | 23,506 |
| Shares used to settle payroll tax withholding | — | — | — | — | (583,936) | — | (10,112) | — | — | — | (10,112) |
| Repurchases of common stock | — | — | — | — | (15,249,782) | — | — | — | — | (227,047) | (227,047) |
| Common stock issued for services | — | — | — | — | 240,663 | — | 3,737 | — | — | — | 3,737 |
| Common stock issued to acquire intangible asset in prior period | — | — | — | — | 43,573 | — | — | — | — | — | — |
| Capped call options, net of tax | — | — | — | — | — | — | (49,413) | — | — | — | (49,413) |
| Substantial premium on convertible debt, net of tax | — | — | — | — | — | — | 13,826 | — | — | — | 13,826 |
| Net loss | — | — | — | — | — | — | — | (65,424) | — | — | (65,424) |
| Other comprehensive income, net of tax | — | — | — | — | — | — | — | — | 28 | — | 28 |
| Balance as of December 31, 2024 | — | — | — | — | 163,195,788 | 18 | 961,434 | 320,302 | 173 | (227,047) | 1,054,880 |
| Issuance of Series A preferred stock, net of issuance costs | 400,000 | 413,611 | — | — | — | — | — | — | — | — | — |
| Stock-based compensation | — | — | — | — | 788,769 | — | 31,033 | — | — | — | 31,033 |
| Shares used to settle payroll tax withholding | — | — | — | — | (318,460) | — | (10,919) | — | — | — | (10,919) |
| Common stock issued upon public offering, net of issuance costs | — | — | — | — | 13,590,908 | 1 | 724,208 | — | — | — | 724,209 |
| Common stock issued for services | — | — | — | — | 55,920 | — | 4,038 | — | — | — | 4,038 |
| Common stock issued for intangible asset acquired in prior period | — | — | — | — | 43,573 | — | — | — | — | — | — |
| Issuance of warrant, net of issuance costs | — | — | — | — | — | — | 261,176 | — | — | — | 261,176 |
| Net loss | — | — | — | — | — | — | — | (85,874) | — | — | (85,874) |
| Other comprehensive income, net of tax | — | — | — | — | — | — | — | — | 214 | — | 214 |
| Other | — | — | — | — | 1,149 | — | — | — | — | — | — |
| Balance as of December 31, 2025 | 400,000 | $413,611 | — | $— | 177,357,647 | $19 | $1,970,970 | $234,428 | $387 | $(227,047) | $1,978,757 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the year ended December 31, | |||
|---|---|---|---|
| (U.S. dollars in thousands) | 2025 | 2024 | 2023 |
| Operating activities: | |||
| Net income (loss) | $(85,874) | $(65,424) | $24,307 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Depreciation, depletion and amortization | 89,267 | 78,057 | 55,709 |
| Accretion of discount on short-term investments | (24,087) | (30,255) | (26,316) |
| Gain on early extinguishment of debt | — | (52,911) | — |
| Stock-based compensation expense | 30,163 | 23,183 | 25,236 |
| Amortization of debt discount and debt issuance costs | 5,412 | 3,901 | 3,536 |
| Write-downs of inventories | 3,038 | 21,527 | 2,285 |
| Deferred income taxes | (30,393) | (27,775) | 8,455 |
| Other | (7,082) | 4,837 | 1,716 |
| Decrease (increase) in operating assets: | |||
| Trade accounts receivable (including related party) | 4,003 | (8,931) | 23,133 |
| Income taxes receivable | 22,668 | (22,842) | 1,371 |
| Other receivables | (110,439) | (36) | (18,028) |
| Inventories | (115,019) | (41,537) | (47,099) |
| Prepaid expenses, other current and non-current assets | (8,959) | (1,676) | (574) |
| Increase (decrease) in operating liabilities: | |||
| Accounts payable and accrued liabilities | 9,392 | 1,332 | 11,305 |
| Income taxes payable | 360 | — | (21,163) |
| Deferred revenue | 58,190 | 100,000 | — |
| Deferred government grant | 4,826 | 4,911 | 19,120 |
| Other current and non-current liabilities | (1,221) | 26,988 | (294) |
| Net cash provided by (used in) operating activities | (155,755) | 13,349 | 62,699 |
| Investing activities: | |||
| Additions to property, plant and equipment | (172,375) | (186,418) | (261,897) |
| Purchases of short-term investments | (1,819,026) | (1,567,983) | (1,185,477) |
| Proceeds from sales of short-term investments | 176,074 | 166,371 | 507,736 |
| Proceeds from maturities of short-term investments | 1,571,342 | 1,597,991 | 1,015,190 |
| Investment in equity method investee | — | — | (9,673) |
| Proceeds from return of investment in equity method investee | 9,673 | — | — |
| Proceeds from sale of property, plant and equipment | 4,063 | — | 18 |
| Proceeds from government awards used for construction | 24,200 | 96 | 2,800 |
| Net cash provided by (used in) investing activities | (206,049) | 10,057 | 68,697 |
| Financing activities: | |||
| Proceeds from issuance of long-term debt | 61,540 | 747,500 | — |
| Proceeds from issuance of common stock | 747,500 | — | — |
| Proceeds from issuance of Series A preferred stock | 299,402 | — | — |
| Proceeds from issuance of warrant | 189,058 | — | — |
| Payment of debt issuance costs | (3,780) | (20,648) | — |
| Payments to retire long-term debt | — | (428,599) | — |
| Payment of equity issuance costs | (31,104) | — | — |
| Purchase of capped call options | — | (65,332) | — |
| Repurchases of common stock | — | (225,068) | — |
| Principal payments on debt obligations | (6,137) | (2,532) | (2,732) |
| Tax withholding on stock-based awards | (10,919) | (10,112) | (7,185) |
| Net cash provided by (used in) financing activities | 1,245,560 | (4,791) | (9,917) |
| Net change in cash, cash equivalents and restricted cash | 883,756 | 18,615 | 121,479 |
| Cash, cash equivalents and restricted cash beginning balance | 283,603 | 264,988 | 143,509 |
| Cash, cash equivalents and restricted cash ending balance | $1,167,359 | $283,603 | $264,988 |
| Reconciliation of cash, cash equivalents and restricted cash: | |||
| Cash and cash equivalents | $1,166,011 | $282,442 | $263,351 |
| Restricted cash, current | 810 | 812 | 1,290 |
| Restricted cash, non-current | 538 | 349 | 347 |
| Total cash, cash equivalents and restricted cash | $1,167,359 | $283,603 | $264,988 |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1—DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
Description of Business: MP Materials Corp., including its subsidiaries (the “Company” or “MP Materials”), is the largest producer of rare earth materials in the Western Hemisphere. Headquartered in Las Vegas, Nevada, the Company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility (“Mountain Pass”) located near Mountain Pass, San Bernardino County, California, the only rare earth mining and processing site of scale in North America. Rare earth products are critical inputs in hundreds of existing and emerging clean-tech applications including electric vehicles and wind turbines as well as robotics, drones, and defense applications. Additionally, the Company owns and operates a rare earth metal, alloy and magnet manufacturing facility in Fort Worth, Texas (the “Independence Facility”), where the Company produces and sells magnetic precursor products and commenced manufacturing of neodymium-iron-boron (“NdFeB”) permanent magnets in December 2025. The Company’s operations are organized intotwo reportable segments: Materials and Magnetics. See Note 22, “Segment Reporting,” for additional information.
The Materials segment represents the upstream and midstream operations of the Company, which primarily consist of Mountain Pass, a fully integrated mining and refining facility producing refined rare earth oxides and related products. The Materials segment generates revenue primarily from sales of neodymium-praseodymium (“NdPr”) oxide and metal, primarily sold to customers in Japan, South Korea, and broader Asia. The Materials segment historically generated the majority of its revenue from sales of rare earth concentrate primarily to a distributor that, in turn, typically sold that product to refiners in China.
The Magnetics segment represents the downstream magnet manufacturing and related operations of the Company, which currently consist of the Independence Facility, a fully integrated metal, alloy, and magnet manufacturing plant. The Magnetics segment began generating revenue from sales of magnetic precursor products to General Motors Company (NYSE: GM) (“GM”) in the U.S. in the first quarter of 2025.
On July 9, 2025, the Company entered into definitive agreements with the United States Department of War (the “DoW”), formerly known as the Department of Defense, (collectively, the “DoW Transaction Agreements”) establishing a transformational public-private partnership with the DoW to accelerate the build-out of an end-to-end U.S. rare earth magnet supply chain and reduce foreign dependency (the “DoW Transactions”). This partnership is further described in Note 3, “Public-Private Partnership with U.S. Department of War,” which includes certain defined terms related to the DoW Transaction Agreements.
In connection with the DoW Transactions, the Company will expand its Independence Facility, construct a second domestic magnet manufacturing facility (the “10X Facility”) and extend its heavy rare earth elements (“HREE”) refining capability at Mountain Pass. Additionally, as outlined in the DoW Offtake Agreement, the DoW has guaranteed that the 10X Facility will generate at least $140 million of EBITDA (as defined in the DoW Offtake Agreement, and subject to annual escalation) and has the right to purchase all of the magnets produced at the 10X Facility (which may instead be commercially syndicated). Separately, the Company entered into an NdPr price floor protection agreement with the DoW (the “Price Protection Agreement” or “PPA”) for the Company’s NdPr products produced at Mountain Pass that are sold or produced and stockpiled starting in the fourth quarter of 2025.
The cash flows and profitability of the Company’s operations have historically been significantly affected by the market price of rare earth products, which are generally also impacted by taxes and tariffs. While this volatility will be reduced following the effectiveness of the PPA, certain exposure to market prices remains. The prices of rare earth products are affected by numerous factors beyond the Company’s control. The products of the Company are sold globally, with a focus on accelerating the development of a U.S. supply chain, with export products primarily sold in the Asian market due to the metallization and magnet manufacturing capabilities of the region. See the“Concentration of Risk” section in Note 2, “Significant Accounting Policies,” for additional information.
Basis of Presentation: The Consolidated Financial Statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”), with the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”), and are presented in U.S. dollars.
NOTE 2—SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation: The Consolidated Financial Statements include the accounts of MP Materials Corp. and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.